School of Medicine
Showing 321-330 of 465 Results
-
Vishnu Ravi
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Vishnu Ravi combines his expertise as a board-certified, practicing internal medicine physician, senior software engineer, and board-certified clinical informaticist to create transformative solutions for healthcare.
As the Technology Architect for Stanford Medicine Catalyst, the Stanford School of Medicine's flagship innovation program, he designs, develops, and implements innovations including AI-driven platforms for Parkinson's care, chronic cardiovascular disease management, and precision pharmacogenomics that are helping patients receive more personalized and effective care.
At the Stanford Mussallem Center for Biodesign, Vishnu helps lead the center's digital health initiatives spanning education, research, and translation. To support this work, he co-founded Stanford Spezi, an open-source framework and ecosystem for building modular, standards-based digital health solutions that is now used by leading healthcare institutions and companies worldwide.
Vishnu also instructs Stanford's CS342/MED253 Building for Digital Health, an innovative course that brings together computer science, engineering, and medical students with clinical faculty to develop real-world healthcare applications. In 2025, he helped lead the international expansion of this program, with a successful launch at Chalmers University of Technology and University of Gothenburg in Sweden. He is also deeply involved in the effort to weave AI into the medical school curriculum at Stanford.
Vishnu's entrepreneurial experience includes co-founding a TechStars-backed startup and developing COVID-19 solutions deployed internationally. He has pioneered clinical AI applications, creating conversational agents and advanced analytics for unstructured health data, while contributing to international mobile health data standards. He serves as a technical consultant to companies including Google and speaks regularly at industry conferences.
Alongside his technology work, Vishnu maintains his connection to clinical practice as an Internal Medicine physician providing comprehensive primary care to a diverse patient population at Stanford Health Care. -
David Rehkopf
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, of Health Policy and of Sociology
BioI am a social epidemiologist and serve as a Professor in the Department of Epidemiology and Population Health and in the Department of Medicine in the Division of Primary Care and Population Health. I joined the faculty at Stanford School of Medicine in 2011.
I am Director of the Stanford Center for Population Health Sciences. In this position, I am committed to making high-value data resources available to researchers across disciplines in order to better enable them to answer their most pressing clinical and population health questions.
My own research is focused on understanding the health implications of the myriad decisions that are made by corporations and governments every day - decisions that profoundly shape the social and economic worlds in which we live and work. While these changes are often invisible to us on a daily basis, these seemingly minor actions and decisions form structural nudges that can create better or worse health at a population level. My work demonstrates the health implications of corporate and governmental decisions that can give the public and policy makers evidence to support new strategies for promoting health and well-being. In all of his work, I have a focus on the implications of these exposures for health inequalities.
Since often policy and programmatic changes can take decades to influence health, my work also includes more basic research in understanding biological signals that may act as early warning signs of systemic disease, in particular accelerated aging. I examine how social and economic policy changes influence a range of early markers of disease and aging, with a particular recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop new more sensitive ways to understand the health implications of social and economic policy changes.
